Shengjun Mao

Key Laboratory Of Drug Targeting And Drug Delivery System Of The Education Ministry And Sichuan Province
Chengdu, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

BETMB: A Dual-Target Compound for Synergistic Suppression of Neuronal Hyperexcitability in Refractory Epilepsy via Concurrent Modulation of Nav Channels and GABAA Receptors.

BETMB: A Dual-Target Compound for Synergistic Suppression of Neuronal Hyperexcitability in Refractory Epilepsy via Concurrent Modulation of Nav Channels and GABAA Receptors.

Journal: CNS neuroscience & therapeutics

Published: October 31, 2025

A Comprehensive Insight of Mechanisms of Drugs Targeting Ion Channels: Exemplified by Marine Natural Products and Their Analogues.

A Comprehensive Insight of Mechanisms of Drugs Targeting Ion Channels: Exemplified by Marine Natural Products and Their Analogues.

Journal: Medicinal research reviews

Published: October 13, 2025

Corrigendum to "IFN-γ gene loaded human umbilical mesenchymal stromal cells targeting therapy for Graft-versus-host disease" [Int. J. Pharm. 592 (2021) 120058].

Corrigendum to "IFN-γ gene loaded human umbilical mesenchymal stromal cells targeting therapy for Graft-versus-host disease" [Int. J. Pharm. 592 (2021) 120058].

Journal: International journal of pharmaceutics

Published: February 06, 2025

Corrigendum to "Co-Delivery of Daunorubicin and Homoharringtonine in Folic Acid Modified-Liposomes for Enhancing Therapeutic Effect on Acute Myeloid Leukemia" [Journal of Pharmaceutical Sciences Volume 112 (2023) 123-131].

Corrigendum to "Co-Delivery of Daunorubicin and Homoharringtonine in Folic Acid Modified-Liposomes for Enhancing Therapeutic Effect on Acute Myeloid Leukemia" [Journal of Pharmaceutical Sciences Volume 112 (2023) 123-131].

Journal: Journal of pharmaceutical sciences

Published: December 05, 2024

Corrigendum to "Benzene, 1,2,4-Trimethoxy-5-(2-Methyl-1-Propen-1-yl) Attenuates D-galactose/AlCl3-induced Cognitive Impairment by Inhibiting Inflammation, Apoptosis, and improving Expression of Memory-Related Proteins" [Neuroscience 524 (2023) 242-255].

Corrigendum to "Benzene, 1,2,4-Trimethoxy-5-(2-Methyl-1-Propen-1-yl) Attenuates D-galactose/AlCl3-induced Cognitive Impairment by Inhibiting Inflammation, Apoptosis, and improving Expression of Memory-Related Proteins" [Neuroscience 524 (2023) 242-255].

Journal: Neuroscience

Published: November 18, 2024

Inhibition of spreading depolarizations by targeting GABAA receptors and voltage-gated sodium channels improves neurological deficits in rats with traumatic brain injury.

Inhibition of spreading depolarizations by targeting GABAA receptors and voltage-gated sodium channels improves neurological deficits in rats with traumatic brain injury.

Journal: British journal of pharmacology

Published: October 31, 2024

Genetically Supported Drug Targets and Dental Traits: A Mendelian Randomization Study.

Genetically Supported Drug Targets and Dental Traits: A Mendelian Randomization Study.

Journal: Journal of dental research

Published: October 07, 2024

Alpha-asarone alleviates cutaneous hyperalgesia by inhibiting hyperexcitability and neurogenic inflammation via TLR4/NF-κB/NLRP3 signaling pathway in a female chronic migraine rat model.

Alpha-asarone alleviates cutaneous hyperalgesia by inhibiting hyperexcitability and neurogenic inflammation via TLR4/NF-κB/NLRP3 signaling pathway in a female chronic migraine rat model.

Journal: Neuropharmacology

Published: May 15, 2024

Corrigendum to "IFN-γ gene loaded human umbilical mesenchymal stromal cells targeting therapy for Graft-versus-host disease" [Int. J. Pharm. 592 (2021) 120058].

Corrigendum to "IFN-γ gene loaded human umbilical mesenchymal stromal cells targeting therapy for Graft-versus-host disease" [Int. J. Pharm. 592 (2021) 120058].

Journal: International journal of pharmaceutics

Published: March 25, 2024

Alpha‑Asarone Ameliorates Neuronal Injury After Ischemic Stroke and Hemorrhagic Transformation by Attenuating Blood-Brain Barrier Destruction, Promoting Neurogenesis, and Inhibiting Neuroinflammation.

Alpha‑Asarone Ameliorates Neuronal Injury After Ischemic Stroke and Hemorrhagic Transformation by Attenuating Blood-Brain Barrier Destruction, Promoting Neurogenesis, and Inhibiting Neuroinflammation.

Journal: Molecular neurobiology

Published: December 18, 2023

Benzene, 1,2,4-Trimethoxy-5-(2-Methyl-1-Propen-1-yl) Attenuates D-galactose/AlCl3-induced Cognitive Impairment by Inhibiting Inflammation, Apoptosis, and improving Expression of Memory-Related Proteins.

Benzene, 1,2,4-Trimethoxy-5-(2-Methyl-1-Propen-1-yl) Attenuates D-galactose/AlCl3-induced Cognitive Impairment by Inhibiting Inflammation, Apoptosis, and improving Expression of Memory-Related Proteins.

Journal: Neuroscience

Published: December 01, 2022

Alpha-Asarone Ameliorates Neurological Dysfunction of Subarachnoid Hemorrhagic Rats in Both Acute and Recovery Phases via Regulating the CaMKII-Dependent Pathways.

Alpha-Asarone Ameliorates Neurological Dysfunction of Subarachnoid Hemorrhagic Rats in Both Acute and Recovery Phases via Regulating the CaMKII-Dependent Pathways.

Journal: Translational stroke research

Published: November 01, 2022

Showing 1-12 of 26

Last Updated: 09/26/2026